Automated computer-based training that focuses on positive words and images helps prolong the antidepressant effects of ketamine for those with treatment-resistant depression.
Patients with major depressive disorder who experienced trauma during childhood see symptom improvement following psychopharmacological intervention, psychotherapy, or a combination of both.
Psychostimulants increase dopamine levels, enhancing task-relevant cortical signals by acting on the striatum and the difference in dopamine synthesis capacity in the striatum explains the variability in the drugs' cognitive effects.
Study reveals a 44% reduction in suicidal events, including suicide attempts and self-harm, in depressed patients who took folic acid supplements.
Those with treatment-resistant depression showed significant improvement in symptoms and became more receptive to positive experiences following a one-week ketamine treatment regimen.
A new identifies a specific gene that regulates neural progenitor cell proliferation in response to lithium for those with bipolar depression.
Effective neurochemical changes in the brain of those with social anxiety take different forms after SSRI treatment and cognitive behavioral therapy.
Study reveals the basic neurobiology of how psychedelics work at the chemical, molecular, neural, and network levels within the brain.
Premenstrual dysphoric disorder (PMDD) is a severe mood disorder that affects one in twenty women. PMDD can have a debilitating impact on the lives of sufferers. Researchers investigate PMDD and evaluate treatment options for sufferers.
Study reveals mindfulness-based stress reduction methods proved to be as effective as antidepressants for relieving symptoms for those with anxiety disorders.
Examining the gut microbiome of those with major depressive disorder, researchers identify the presence of the bacteria Faecalibacterium prausnitzii as being responsible for the functional discrepancies between healthy individuals and those with MDD.
A newly developed vaccine blocks the ability of the opioid Fentanyl's ability to enter the brain, thus blocking the drug's "high".
